These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 24047697)
1. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness. Sisci D; Maris P; Cesario MG; Anselmo W; Coroniti R; Trombino GE; Romeo F; Ferraro A; Lanzino M; Aquila S; Maggiolini M; Mauro L; Morelli C; Andò S Cell Cycle; 2013 Nov; 12(21):3405-20. PubMed ID: 24047697 [TBL] [Abstract][Full Text] [Related]
2. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Belguise K; Guo S; Sonenshein GE Cancer Res; 2007 Jun; 67(12):5763-70. PubMed ID: 17575143 [TBL] [Abstract][Full Text] [Related]
3. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER. Zekas E; Prossnitz ER BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790 [TBL] [Abstract][Full Text] [Related]
4. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651 [TBL] [Abstract][Full Text] [Related]
5. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Guo S; Sonenshein GE Mol Cell Biol; 2004 Oct; 24(19):8681-90. PubMed ID: 15367686 [TBL] [Abstract][Full Text] [Related]
6. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. Madureira PA; Varshochi R; Constantinidou D; Francis RE; Coombes RC; Yao KM; Lam EW J Biol Chem; 2006 Sep; 281(35):25167-76. PubMed ID: 16809346 [TBL] [Abstract][Full Text] [Related]
7. Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells. Morelli C; Lanzino M; Garofalo C; Maris P; Brunelli E; Casaburi I; Catalano S; Bruno R; Sisci D; Andò S Mol Cell Biol; 2010 Feb; 30(3):857-70. PubMed ID: 19933843 [TBL] [Abstract][Full Text] [Related]
8. 17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells. Sisci D; Middea E; Morelli C; Lanzino M; Aquila S; Rizza P; Catalano S; Casaburi I; Maggiolini M; Andò S Breast Cancer Res Treat; 2010 Nov; 124(1):63-77. PubMed ID: 20052536 [TBL] [Abstract][Full Text] [Related]
9. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis. Belguise K; Sonenshein GE J Clin Invest; 2007 Dec; 117(12):4009-21. PubMed ID: 18037997 [TBL] [Abstract][Full Text] [Related]
10. Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma. Sreekumar S; Levine KM; Sikora MJ; Chen J; Tasdemir N; Carter D; Dabbs DJ; Meier C; Basudan A; Boone D; McAuliffe PF; Jankowitz RC; Lee AV; Atkinson JM; Oesterreich S Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32609836 [TBL] [Abstract][Full Text] [Related]
11. Modulation of 17β-Estradiol Signaling on Cellular Proliferation by Caveolin-2. Totta P; Gionfra F; Busonero C; Acconcia F J Cell Physiol; 2016 Jun; 231(6):1219-25. PubMed ID: 26480297 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha. Han L; Liu B; Jiang L; Liu J; Han S Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360 [TBL] [Abstract][Full Text] [Related]
13. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer. Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091 [TBL] [Abstract][Full Text] [Related]
14. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice. Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007 [TBL] [Abstract][Full Text] [Related]
15. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance. Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560 [TBL] [Abstract][Full Text] [Related]
16. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo. Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256 [TBL] [Abstract][Full Text] [Related]
17. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Kondo N; Toyama T; Sugiura H; Fujii Y; Yamashita H Cancer Res; 2008 Jul; 68(13):5004-8. PubMed ID: 18593897 [TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer. Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638 [TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer. Swetzig WM; Wang J; Das GM Oncotarget; 2016 Mar; 7(13):16049-69. PubMed ID: 26909605 [TBL] [Abstract][Full Text] [Related]
20. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer. Chen J; Gomes AR; Monteiro LJ; Wong SY; Wu LH; Ng TT; Karadedou CT; Millour J; Ip YC; Cheung YN; Sunters A; Chan KY; Lam EW; Khoo US PLoS One; 2010 Aug; 5(8):e12293. PubMed ID: 20808831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]